Why the study?
Does oral polio vaccine induce seroconversion in neonates aged 1-6 weeks comparable to older infants?
Does oral polio vaccine induce seroconversion in neonates aged 1-6 weeks comparable to older infants?
Oral polio vaccine is effective in inducing seroconversion in neonates as young as 1 week old, suggesting the immunization age limit could be reduced.
Answers are grounded in this paper and cite their sources.
May support earlier OPV initiation in neonates; leaves open schedule changes pending randomized confirmation.
Newborn children 1 to 6 weeks of age were given oral polio vaccines to see whether the age limit of 6-8 weeks for the current Indian immunization program could be reduced. 180 neonates received oral polio vaccines followed by 2nd and 3rd doses at 4 week intervals. Breast feeding was delayed 30 minutes after vaccination. In 139 infants tested after the 3rd dose the titers against type 1 2 or 3 polio virus expressed as percentage of seroconversion did not differ from those seen in groups of children aged 6-20 or 6-51 weeks of age. Babies less than 1 week old were not tested because the literature suggests that their antibody response is inhibited. These results show that maternal antibodies do not prevent local infection by poliovirus in the gut of infants as young as 1 week old.
No takes yet. Share an insight, caveat, or question.
T. Jacob John (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: